remaining on the waitlist. [3] [4] [5] Increased use of marginal kidneys is a possible solution to mitigate the organ shortage. 6 An important challenge hindering the further use of marginal kidneys is that individual candidates' outcomes after DDKT with a marginal kidney may vary. Previous studies reported that certain subgroups, such as younger or nondiabetic recipients, may not receive clear survival benefit from KT with a marginal kidney. 3, 7 Nonetheless, these examples are not granular enough to be used in practice to make individualized decisions to accept or decline a marginal kidney. Identifying whether an individual candidate would obtain survival benefit is of utmost importance to safely increase marginal kidney use. Ongoing concerns include the fact that healthier candidates, who would likely survive for a decade even without immediate KT, may gain little from KT with marginal kidneys. 7, 8 On the other hand, unhealthy candidates may not have the physiological reserve to tolerate KT with marginal kidneys. 9 Little is known about how the candidate condition modifies the effect of donor quality on post-KT outcomes, that is, the interaction between marginal donor quality and candidate condition.
This knowledge gap is a potential reason for the underuse of marginal kidneys, given that uncertainty leads to risk aversion in clinical practice. 10, 11 A marginal kidney offer should be considered more favorably for a candidate who is predicted to receive substantial survival benefit with such a kidney. However, there is no tool to guide this prediction. This uncertainty prompts transplant centers to make a "safe" decision to wait for healthier, lower-risk kidney offers rather than to accept the marginal kidney offer in hand.
Characterizing the interaction between donor quality and candidate condition could facilitate the use of marginal kidneys and expand access to KT for candidates who could tolerate such kidneys, without sacrificing outcomes.
To address this knowledge gap, we aimed to create a simple and intuitive online tool to estimate the post-KT survival by donor quality, specifically to candidate condition. The purpose of this tool was to support evaluation of marginal kidney offers by predicting whether the offered kidney would provide sufficient survival benefit to the candidate under consideration. We used a machine learning method on national registry data to achieve the highest possible prediction performance.
| ME THODS

| Data source
We used data from the Scientific Registry of Transplant Recipients (SRTR). The SRTR data system includes data on all donors, wait- Albeit this shortcoming, the KDPI and EPTS score are relevant to our study because they are currently used in the allocation of deceased donor kidneys in the United States. Clinicians can readily obtain a KDPI of the offered kidneys and an EPTS score of the candidates from the allocation system and are familiar with the concepts of these risk metrics.
| Study population
As such, using these 2 scores, as opposed to directly modeling on donor and recipient clinical characteristics, grants simplicity and improves usability while maintaining clinical relevance. The KDPI and EPTS score were calculated as per the 2016 OPTN mapping tables. 13, 14 We used the random forest algorithm to predict the post-KT survival by KDPI and EPTS score. Random forest algorithms can handle complex interactions between multiple predictors with no knowledge or assumptions on how the predictors will interact with each other. 17, 18 Hence, it allows a more efficient and objective approach to examine the interaction between the KDPI and the EPTS score compared with the generalized linear regression. We used the approach of Ishwaran and colleagues to implement random forest algorithms for survival data. 19 With this approach, we estimated the survival function during the entire follow-up period. However, our tool presents the survival estimates only at 5 and 10 years after KT to ensure simplicity and interpretability in clinical practice. Of note, random forest algorithms do not provide uncertainty measures, such as standard errors in generalized linear models. Ishwaran and colleagues suggested using the C-statistic as an overall measure of predictive performance. 19 The Cstatistic of our model was 0.637, which is slightly higher than that of the original Kidney Donor Risk Index model.
| Waitlist survival
We assigned a hypothetical "entry date" to all candidates. Each candidate's entry date was randomly chosen from the candidate's follow-up period, which began on the first date of active waitlisting and ended on the first date of death, KT, or removal from the waitlist or the end of the study (December 31, 2016) . If the candidate was already actively listed at the beginning of the study, the follow-up period for the candidate started from the beginning of the study (January 1, 2005). Waitlist survival was defined as the time from the entry date to death, censoring for KT, removal from the waitlist, or the end of the study. We calculated the EPTS score as of the entry date for the candidate cohort. However, because the EPTS score of the latter would be accordingly higher to reflect the additional risk accumulated during the 1-year gap, the association between EPTS score and survival will be consistent regardless of when they received the kidney offer.
We tested this assumption with a sensitivity analysis in which we characterized the association between EPTS score and survival at 4 different time points: dialysis initiation and 3, 6, and 9 years since dialysis initiation. Our sensitivity analysis showed that the association between EPTS score and survival is consistent across different time points, suggesting that our method can correctly predict survival based on EPTS score (Supplementary Figure S1 ).
We predicted waitlist survival based on EPTS score by using a In accordance with our post-KT survival analysis, our tool presents the 5-and 10-year waitlist survival data. We used the natural cubic splines to characterize the association between EPTS score and waitlist survival in a flexible, nonlinear functional form. 21 KT is a competing event to death: we used the cause-specific hazard method, as opposed to the subdistribution hazard method, to predict the survival should the candidate remain on waitlist without receiving a KT.
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| Survival benefit
Survival benefit was assessed by calculating the absolute risk reduction in mortality. We estimated the risk difference in percentage points by subtracting post-KT mortality from waitlist mortality.
We also estimated relative risk reduction, or risk ratio, by dividing waitlist mortality by post-KT mortality. For both measures, greater values indicate greater survival benefit from KT. Survival benefit was estimated at 5 and 10 years after KT.
| Missing data
In variables constituting KDPI, and those for the recipient/candidate variables were input from other variables constituting EPTS score. 
| Statistical analysis
| RE SULTS
| Population characteristics
In the recipient cohort (n = 120 818), 33.1% were African American, 39.7% were female, 14.7% had previous transplants, and 18 were female, 11.9% had previous transplants, and 14.0% had peak PRA values of ≥80. Median age at waitlisting was 54 years (Table 1) .
| Post-KT survival
In the recipient cohort, the predicted post-KT survival was 84.3% ( (Table 2 ).
| Waitlist survival
In the candidate cohort, the predicated waitlist survival was 59.2%
(95% CI, 58.8%-59.6%) at 5 years and 35.2% (95% CI, 33.7%-36.9%) F I G U R E 2 Survival benefit of receiving a kidney transplant vs remaining on waitlist based on Estimated Post Transplant Survival (EPTS) score and Kidney Donor Profile Index (KDPI) value. Survival benefit was defined as the reduction in mortality risk with a kidney transplant (KT). Darker color indicates a greater survival benefit. A. Risk difference, defined as waitlist mortality minus post-KT mortality, decreased with higher KDPI. The decrease was only slight with low EPTS score and more pronounced with middle or high EPTS score. However, even with the highest values of KDPI, individuals with a middle or high EPTS score are expected to receive substantial survival benefit (>16 percentage-points). B. Risk ratio, defined as waitlist mortality divided by post-KT mortality, decreased as KDPI increased, particularly when EPTS score was low (Table 2) .
| Survival benefit
The risk difference in 5-year mortality ranged from 2.1 percentage points with an EPTS score of 1 and a KDPI of 100 to 32.2 percentage points with an EPTS score of 96 and a KDPI of 1 (Figure 2A) 
| D ISCUSS I ON
In this study of a large nationwide registry of transplant recipients, we estimated post-KT survival and waitlist survival by KDPI and EPTS score, using a machine learning algorithm that can address interactions between the 2 predictors. Receiving KT was associated with a lower mortality risk than was remaining on the waitlist in all combinations of KDPI and EPTS score, with reduction in 5-year mortality ranging from 2.1 to 32.2 percentage points. More importantly, the effect of KDPI on survival benefit was modified by EPTS score, suggesting that the potential impact of marginal donor quality should be assessed according to the candidate's condition. The survival estimates from our models are presented on simple contour plots included here. We also created an online tool (www.transplantmodels.com/kdpi-epts) that offers an interactive visualization of the impact of KDPI on survival benefit for a specific EPTS score value . In other words, the survival benefit that middle-and high-EPTS candidates would receive from the highest-KDPI kidneys is comparable to the survival benefit that low-EPTS candidates would receive from the lowest-KDPI kidneys.
Our tool can improve the process of evaluating a kidney offer in several ways. First, the estimates from our tool are specific to the candidate's condition. We found that the impact of marginal kidney quality on post-KT survival varies substantially by the recipient's health condition. Second, our tool predicts survival benefit not only with the currently offered kidney but also with potential better-quality kidneys that may become available in the future. A comparison of these estimates may help in deciding whether to accept the current kidney offer or to decline it and wait for another. Last, the simplicity of our model opens a possibility for shared decision-making.
Individual candidates waiting for KT have different expectations on their waitlist survival and post-KT survival. 25 Hence, candidates would have their own perspectives on how much survival benefit is sufficient to justify the surgical stress, the life-long immunosuppression, and the financial burden associated with KT. initial reference to determine whether waiting for a better kidney would be at all meaningful for the specific candidate under consideration, even before consulting more complex models discussed here earlier to predict the candidate's chance of receiving a better kidney in the future.
Our tool may also lead to an improved use of high-KDPI kidneys.
Despite the severe shortage of kidneys available for transplant, the use of high-KDPI kidneys is very limited. Half of the kidneys with a KDPI of 81 to 100 are discarded, despite the fact that they were initially deemed acceptable and procured for KT. 2 Even among the kidneys that are eventually transplanted, finding a transplant center that is willing to accept a marginal kidney is often a lengthy and challenging process. A recent study 28 reported that one-fourth of the kidneys that were eventually transplanted were declined at least 73 times before being accepted. Donor quality was the most frequently stated reason for decline: 30.7% of the offers were declined due to "donor age or quality," and 13.3% were bypassed (ie, automatically declined) because "minimal acceptance criteria were not met." Our findings on the interaction between donor quality and candidate condition may reduce unnecessary discard of marginal yet viable kidneys. Using our tool, clinicians can assess whether the offered marginal kidney would confer sufficient survival benefit to the individual candidate under consideration, rather than taking a riskaverse approach that could remove an opportunity for KT from those who could have benefitted from it.
While we used absolute risk reduction as our primary measure of survival benefit, we also estimated relative risk reduction. Absolute risk reduction is generally more relevant to guiding clinical decisions, whereas relative risk reduction is more relevant to characterizing associations. 29, 30 The risk ratios shown in Figure 2B provide an overview of the interaction between EPTS score and KDPI on survival benefit. The impact of the KDPI on survival benefit appears to be the mildest when the KDPI is low and the EPTS score is high (upper left quadrant in Figure 2B ) and the greatest when the KDPI is high and the EPTS score is low (lower right quadrant in Figure 2B ). This finding supports that declining high-KDPI kidney offers and waiting for lower-KDPI kidneys could still be a viable strategy for some low-EPTS candidates.
Our study has several limitations. First, the combinations of KDPI and EPTS score observed in our study are the result of a selection process; in other words, some clinician at some point thought this combination was good, and the bad combinations might have more likely been declined by savvy clinicians. Hence, some of the extreme cases, such as a very low EPTS score and a very high KDPI, might be results of circumstances that necessitate unusual (not commonly practiced or seen) combinations of KDPI and EPTS score.
Also, the extremes are likely more extrapolative than the middle cases. Estimates from such cases should be interpreted with caution. Similarly, our prediction model is based on the data of transplanted kidneys. Applying this model to kidneys with extremely high KDPI requires caution because a select subset of such kidneys are transplanted. Last, our tool does not include several key factors such as center-specific (or even provider-specific) organ supply and aggressiveness and the clinical and socioeconomic factors that do not constitute KDPI or EPTS score (eg, histocompatibility between the donor and the recipient and the recipient's health insurance status). While these are important predictors of post-KT survival, we decided to focus on KDPI and EPTS score because our scope was to create a simple tool that can serve as a quick reference for accepting or declining marginal kidney offers.
In conclusion, we have developed a unique, simple, providerfriendly tool to predict waitlist survival and post-KT survival for any
given combination of donor quality and candidate condition. Our tool provides an individualized prediction of survival benefit from the offered kidney as well as potential better-quality kidneys, assisting clinicians in determining whether to accept the currently offered kidney or to wait for a better-quality kidney offer. Our tool is also simple to use and easy to understand, as it requires only an EPTS score and a KDPI value from the user and presents the estimates visually. We expect that this tool may reduce unnecessary discards and assist with appropriate recipient selection for all kidneys from deceased donors.
